600223.SS
600223.SS
CNE000001147
LUSHANG FREDA PHARMACEUTICAL CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.650.898.044 3.982.577.120
8.3%
Cost of Revenue 1.724.709.979 1.884.547.089
8.5%
Gross Profit 1.926.188.065 2.098.030.031
8.2%
1.717.989.969 1.820.671.600
5.6%
Operating Income 208.198.096 277.358.431
24.9%
Pretax Income 284.875.963 346.293.632
17.7%
Net Income Common Stockholders 187.751.525 243.525.296
22.9%
-- --
--
-- --
--
ende